OVARIAN CANCER

For what age women should be preventive ovariectomy, between different gynecological physician there is a considerable difference. Jacobs Oram and the Royal College of Obstetrics and Gynecology doctors on preventive attitude ovariectomized done a survey, the results showed that: only 2% to gynecologists for women aged 40 to 44 the ovary; 20% of doctors agreed with 45 to 49-year-old women's ovary; 51% think Resectability aged over 49-year-old women's ovary; 85% agree that postmenopausal women with ovarian. Alaska gynecologists, 35% agree with women aged 40 to 44 the ovary; 81% agree with women aged 45 to 49 the ovary; 95% agree with women over the age of 49, the ovary.
Some of the literature suggested that the age for women aged ≥ 40 ovariectomized preventive purposes. However, while some other articles that only deal with ≥ 45 years of age patients with preventive ovariectomy. It is clear that the majority of women with ovarian also not aware of estrogen replacement therapy (estrogen replacement therapy, ERT) the importance, from the reported in the literature it is not difficult to see that the compliance ERT not ideal, however, the role of estrogen loss is real. After ovariectomy, the ERT begin compliance was 31% to 89%; The long-term application, a decrease of 13% to 51%. Under existing ERT compliance of the relevant information can be estimated preventive ovariectomized will lead to the age of 45 or more young women to shorten life expectancy. For example, a 35-year-old women, in preventive ovary after, if they failed to ERT, then her life expectancy will decrease 1.4 years. Siddle, proved to hysterectomy for women, ovarian failure will be the age of natural menopause, as early as four years (45.4? ? .0 49.5-right? ? .04), And 34% of women in the two years after emerging ovarian failure and menopause symptoms .
Thus, clinicians must be aware of ovarian hysterectomy after reservation for women should be ahead of ERT treatment.

Tags: age, early, eat, ert, estrogen, gynecological, head, life, ovarian, ovary, patients, preventive, symptoms, therapy, treatment, women

1. Bilateral abdominal tumor malignant ovarian tumor growth, both accounting for 75%, and bilateral benign ovarian tumor was only 15%.

2. Mass fixed One of the characteristics of ovarian cancer.

3. Although ascites benign ovarian tumors such as fibroids or papillary also cystadenoma with ascites, malignant ovarian tumor with ascites more, and because of the cancer cell wall or piercing has been transferred to peritoneal (Head seized observation or examination), a sustained bloody ascites.

4. Cachexia course of a long delay, due to long-term consumption, loss of appetite and weight loss sexual performance, fatigue, malaise and cachexia symptoms.

Tags: abdominal, benign, blood, cancer, cause, cell, cyst, examination, fat, growth, head, malignant, mass, ovarian, symptoms, tumor, tumors

Ovarian cancer is the gynecologic diseases, from childhood to old age may occur, according to the degree of malignancy, into benign and malignant tumors of the junction. Ovarian located in the pelvis, as superficial malignant easy aware of the organization, are often found already late, is the main threat to women's health malignancy. Slower development of benign ovarian tumors, small benign tumor more asymptomatic; Medium-sized benign tumor may have bloating and abdominal discomfort, patients often palpable mass, the tumor can produce tremendous oppression symptoms. The rapid tumor growth, invasion to the surrounding tissue, cause abdominal pain, bloating, bleeding, vaginal bleeding; Merger fever infection; Tumor necrosis have ulcers, bloody ascites, advanced with weight loss, fatigue, anemia, cachexia performance. 

Tags: abdominal, age, benign, bleeding, blood, cancer, cause, diet, eat, fat, growth, head, malignant, mass, oppression, ovarian, pain, patients, symptoms, tea, tumor, tumors, women

Ovarian cancer

Tags: abdominal, age, benign, bleeding, blood, body, cancer, cause, cell, cells, clinical, cyst, examination, fat, growth, head, malignant, mass, ovarian, pain, second, symptoms, tumor, tumors, women

Ovarian cancer mortality first Habitat gynecologic malignancies, as misprision of onset, 70% of patients when treatment is already advanced. Surgery and chemotherapy comprehensive application is the treatment of advanced ovarian cancer, especially epithelial ovarian cancer therapy of choice. Platinum drug resistance ovarian cancer is the main reason for treatment failure. To solve this problem, clinical oncologist to a variety of solutions, is chosen in 2003 after the open literature on the following:

Tags: anti, cancer, carboplatin, cases, cell, cells, chemotherapy, cisplatin, clinical, csa, days, dose, drug, drugs, eat, head, injection, intravenous, method, ovarian, paclitaxel, patients, positive, rate, reduce, response, study, surgery, survival, therapy, time, toxicity, treatment

Clinical manifestations

(1) a <BR> symptoms, age occurred in perimenopausal women. Over more than 35 years of epithelial ovarian cancer, while those below the age of 35 occurred reproductive cell malignancies.
2, the pain may be due to malignant ovarian tumor of the changes, such as hemorrhage, necrosis, the rapid growth caused a considerable degree of persistent pain. The inspection found a local tenderness.
3, Irregular Menstruation see irregular bleeding, bleeding after menopause.
4, weight loss was sexually advanced thin.

Tags: abdominal, age, annex, anti, benign, bleeding, blood, body, cancer, cases, cause, cell, cells, chemotherapy, clinical, cyst, diagnosis, drug, drugs, eat, examination, exploration, fat, gene, growth, head, irradiation, life, lymph, malignant, mass, node, ovarian, pain, patients, pelvic, poor, positive, radiation, radiotherapy, resection, response, second, staging, surgery, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors, women

In Orlando at the American Association for Cancer Research annual meeting, Philadelphia's Fox Chase Cancer Center researchers proposed a new research results, analgesic drugs such as aspirin, ibuprofen, Celebrex and Vioxx could help prevent ovarian cancer, these common anti-inflammatory drugs could inhibit cox 2 enzyme, may be able to slow the rapid ovarian cell changes, and can reduce the formation of malignant cells potential risks.

The study leader Xiang-Xi (Mike) Xu said that the cox-2 enzyme have a role in the process is unusual mechanism. When we released the report, it is obvious that this truth, but before this mechanism was not found.

Tags: administration, age, anti, body, breast, cancer, cause, cell, cells, cox, drug, drugs, early, eat, family, gene, group, gynecological, head, history, life, malignant, ovarian, pain, rate, reduce, risk, study, surface, time, treatment, tumor, usually, women

Usually that cervical cancer is a certain type of human papilloma virus (HPV) caused. Now Johns Hopkins University researchers think that some head and neck cancer, particularly tongue and tonsil cancer with the following regional HPV infection. They also found that HPV-positive head and neck cancer prognosis, the other with head and neck cancer different.

V. said Dr. Keerti Shah, head and neck cancer usually is not a good prognosis, in the majority of patients the disease is advanced only found. However, HPV-positive cancer under the microscope is obvious characteristics, so pathologists can immediately determine whether the HPV-positive tumors.

Tags: cancer, cases, cause, diagnosis, eat, ert, gene, head, hpv, mutation, neck, p53, patients, positive, prognosis, radiation, risk, study, treatment, tumor, tumors, usually

Abstract: The FDA approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin infusion again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

The United States Food and Drug Administration (FDA) approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin injection again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

Tags: administration, age, anti, blood, breast, cancer, cell, cells, cisplatin, clinical, drug, drugs, eat, fat, grams, head, infusion, injection, neck, ovarian, paclitaxel, patients, radiotherapy, reduce, risk, study, taxol, therapy, toxicity, treatment, women

The incidence of ovarian cancer only to cervical cancer, endometrial cancer, gynecological malignancies in the third. Because ovarian deep in the pelvis, even longer differentiating not easily found. According to statistics, 60% to 70% of newly diagnosed patients have symptoms, is already advanced. Therefore, people should be promptly found ovarian cancer flashed "yellow card" warning.

One month after little or <BR> amenorrhea majority of patients with ovarian cancer menstrual changes. If ovarian cancer cells were normal tissue damage in patients with systemic poor state, there will be a few months or amenorrhea.

Tags: abdominal, age, amenorrhea, bleeding, cancer, cause, cell, cells, eat, ert, estrogen, examination, fat, growth, gynecological, head, incidence, intraperitoneal, lymph, mass, oppression, ovarian, pain, patients, pelvic, poor, reduce, symptoms, time, tumor, tumors, women